Posted by Michael Wonder on 12 Jan 2025
Important milestone for Biotest: biologics license application for fibrinogen submitted to the US FDA
9 January 2025 - The biologics license application for Biotest’s fibrinogen has been submitted to the US FDA.
Fibrinogen is the second product developed and manufactured by Biotest in Dreieich, Germany, for which a biologics license application has been submitted to the FDA.
